Status:
COMPLETED
Trial of Chinese Prescription on Ulcerative Colitis
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription on Ulcerative Colitis.
Eligibility Criteria
Inclusion
- Clinical diagnosis of ulcerative colitis
- Male of female patients between 18-65 years old
- Written informed consent
Exclusion
- Combine with malignant pathology on epithelial dysplasia of mucosa
- Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
- Pregnancy or breast feeding women, or unwilling to have contraception.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00963287
Start Date
August 1 2009
End Date
August 1 2011
Last Update
April 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Longhua hospital
Shanghai, Shanghai Municipality, China, 200032